(Q39005887)

English

Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle

scientific article published on 6 April 2014

In more languages
default for all languages
No label defined

No description defined

Statements

Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit